[86] documented that RG7834, a novel oral HBV gene expression inhibitor, could reduce the levels of viral proteins and lessen viremia. RG7834 is a small-molecule compound belonging into the dihydroquinolizinones chemical class just like RNAi but through a distinct system.Also, a combination of antiviral medication with the immune-modulator could en